Skip to main content
Premium Trial:

Request an Annual Quote

Cellular Dynamics Expands Distribution Deal in Japan

NEW YORK (GenomeWeb News) – Cellular Dynamics today announced it has expanded its distribution deal with iPS Academia Japan to include iCell Neurons and iCell Endothelial Cells.

The deal builds on a distribution agreement forged by the Madison, Wis.-based stem cell technology firm and the affiliate of Kyoto University in June 2011 covering iCardiomyocytes.

Robert Palay, CEO and chairman of CDI, said in a statement, "We view the expansion of our distribution agreement with iPS Academia Japan as a vote of confidence in our ability to provide human [induced pluripotent stem cell-derived] cells in the quantity, quality, and purity required for scientists to realize the full potential of their experiments."

iPS Academia Japan was originally created to manage the patents and technology based on the work of Shinya Yamanaka of Kyoto University, and CDI is the first foreign firm to be granted a license to Yamanaka's iPSC patent portfolio by iPS Academia Japan.

Financial and other terms were not disclosed.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.